deCODE genetics Financial Statements
deCODE genetics Financial Information
| Company Type | Public |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
deCODE genetics Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 58.1 | 40.4 | 40.5 |
| Gross Profit ($ mil.) | 5.6 | (6.6) | (2.2) |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (80.9) | (95.5) | (85.5) |
| Diluted EPS (Net Income) | (1.32) | (1.57) | (1.49) |
deCODE genetics Quarterly Statements
| Quarter Ending Jun 09 | Quarter Ending Mar 09 | Quarter Ending Mar 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 3.5 | 8.9 | 8.9 |
| Gross Profit ($ mil.) | (0.9) | 0.7 | 0.7 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (13.2) | (12.6) | (12.6) |
| Diluted EPS (Net Income) | (0.21) | (0.21) | (0.21) |
deCODE genetics Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.37 | 1.52 | 7.00 |
| Price/Earnings Ratio | (0.29) | 18.69 | 25.45 |
| Price/Book Ratio | (0.07) | 2.57 | 6.74 |
| Price/Cash Flow Ratio | (0.68) | 11.61 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed deCODE genetics Financial Ratios
deCODE genetics Competitive Intelligence
| Celera | Myriad Genetics | Roche Diagnostics | |
|---|---|---|---|
| Annual Sales ($ mil.) | 138.7 | 326.5 | 0.0 |
| Employees | 554 | 869 | 2,000 |
| Market Cap ($ mil.) | 519.5 | 2,347.3 | -- |
Competitive Landscape
